More importantly, treatment with KRASG12C inhibitor AMG 510 in MC38K tumors effectively inhibited tumor growth (Figure 2F,G), and reverted CD8+ T‐cell tumor infiltration (Figure 2H–J). The gene discussed is CD8A; the disease is neoplasm.